2025-09-04 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided. The report is structured with a brief summary at the beginning, followed by detailed sections covering various aspects of the company.

---

## TDOC (Teladoc Health Inc) Analysis

**Summary:** Teladoc Health Inc. is a telehealth company offering virtual healthcare services. TDOC has significantly underperformed the S&P 500, showing high volatility and negative profitability. Recent news suggests significant market interest and volatility, yet financial indicators point to low returns on equity and high risk.

---

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -63.68%
*   **VOO Cumulative Return:** 100.25%
*   **Deviation:** -163.93% (TDOC significantly underperformed VOO)
*   **Deviation Range:** (Max: 456.6, Min: -167.6, Current: -166.9, Relative Deviation: 0.1)

**Analysis:** TDOC's performance is substantially below the S&P 500. The relative deviation of 0.1 indicates that the current deviation is near the lowest end of its historical range, suggesting continued underperformance.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
| :----------- | :------ | :------ | :----- | :---- | :------- |
| 2015-2017  | 76.0%   | 60.6%   | 50.0%  | -0.0  | 6.2      |
| 2016-2018  | 128.0%  | 59.3%   | 110.0% | -0.0  | 8.8      |
| 2017-2019  | 176.0%  | 59.3%   | 147.0% | 0.4   | 14.8     |
| 2018-2020  | 237.0%  | 64.0%   | 217.0% | 0.1   | 35.3     |
| 2019-2021  | -83.0%  | 64.0%   | -132.0% | 0.1   | 16.2     |
| 2020-2022  | -295.0% | 81.3%   | -297.0% | 0.0   | 4.2      |
| 2021-2023  | -488.0% | 81.3%   | -506.0% | -0.6  | 3.8      |
| 2022-2024  | -111.0% | 81.3%   | -137.0% | -0.8  | 1.6      |
| 2023-2025  | -34.0%  | 75.5%   | -85.0%  | -0.8  | 1.4      |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows significant negative values in recent periods, indicating poor historical growth.
*   **MDD:** High Maximum Drawdown values suggest significant risk and volatility.
*   **Alpha:** The negative Alpha values indicate underperformance relative to the market.
*   **Beta:** Beta values near zero or negative indicate low correlation with the market, or inverse price correlation.
*   **Cap(B):** Declining market capitalization indicates a decrease in investor confidence and market value.

### 2. Recent Stock Price Movement

*   **Current Price:** 7.685
*   **Last Market Data:** price: 7.68, previousClose: 7.64, change: 0.52
*   **5-day Moving Average:** 7.771
*   **20-day Moving Average:** 7.3607
*   **60-day Moving Average:** 7.6881

**Analysis:** The current price is slightly below the 5-day moving average and slightly above the 60-day moving average, but above the 20-day moving average, suggesting a potential stabilization after a recent uptrend. The recent 'change' of 0.52 indicates recent upward momentum, which could be interpreted as a minor breakout.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 67.53 (Approaching overbought territory)
*   **PPO:** 0.9967 (Positive, indicating an uptrend)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (103 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent (20-day) Relative Deviation Change:** -0.2 (Negative, indicating a short-term decline in relative performance)
*   **Expected Return (%):** -10213.2 (Extremely negative, suggesting significant underperformance relative to the S&P 500 in the long term)

**Analysis:** The MRI indicates low market risk. The RSI is approaching overbought levels, which might indicate a potential pullback. The negative change in relative deviation suggests recent underperformance compared to the S&P 500. The extremely negative expected return is a major cause for concern, indicating potentially significant long-term losses compared to the index.

### 4. Recent News & Significant Events

*   **2025-09-02:** Major business developments, regulatory changes, or market events.
*   **2025-08-31:** Analyst discussions on performance and outlook considering industry trends and global economic factors.
*   **2025-09-03:** Notable stock volatility influenced by news, earnings reports, or executive actions.
*   **2025-09-04:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news indicates the stock is experiencing volatility and is under scrutiny by analysts, influenced by various factors, including earnings and market events. Investors are advised to monitor news closely due to potential risks and opportunities.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
| :--------- | :---- | :-------- |
| 2025-07-30 | -0.19 | 0.63 B$   |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2025-07-30 | -4.92 | 0.64 B$   |

**Analysis:** The company is consistently reporting negative Earnings Per Share (EPS). While revenue is relatively stable around $0.63-0.64 billion, the significant negative EPS values indicate challenges in profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| :----------- | :------- | :------------ |
| 2025-06-30 | $0.63B  | 69.85%       |
| 2025-03-31 | $0.63B  | 68.73%       |
| 2024-12-31 | $0.64B  | 70.50%       |
| 2024-09-30 | $0.64B  | 71.94%       |
| 2024-06-30 | $0.64B  | 70.73%       |

**Capital and Profitability:**

| Quarter      | Equity  | ROE        |
| :----------- | :------ | :--------- |
| 2025-06-30 | $1.42B  | -2.30%     |
| 2025-03-31 | $1.43B  | -6.52%     |
| 2024-12-31 | $1.49B  | -3.25%     |
| 2024-09-30 | $1.51B  | -2.21%     |
| 2024-06-30 | $1.50B  | -55.77%    |

**Analysis:**

*   **Revenue and Profitability:** While revenue is consistent, the profit margins are relatively high, which could be related to specific accounting practices or one-time gains.
*   **Capital and Profitability:** The consistent negative Return on Equity (ROE) values confirm the company's lack of profitability from an equity perspective. Decreasing equity over the quarters indicates a decline in net assets.

### 7. Overall Analysis

TDOC faces significant challenges. The stock has drastically underperformed the S&P 500, and financial indicators suggest continued struggles with profitability and growth. While revenue is stable, negative EPS and ROE values are concerning. Recent news indicates volatility and market attention. Investors should exercise caution and closely monitor the company's developments and financial performance. The extremely negative expected return makes this a highly risky investment at the current time.
